OverviewSuggest Edit

Nevro Corp. is a medical device company which focuses on providing products for the patients suffering from chronic pain. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Company sells its products through its direct sales force, and a network of sales agents and independent distributors.

TypePublic
Founded2006
HQRedwood City, CA, US
Websitenevro.com
Employee Ratings3.4
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2019)853(+7%)
Job Openings41
Revenue (FY, 2020)$362 M(-7%)
Share Price (Jun 2021)$158.2
Cybersecurity ratingBMore

Key People/Management at Nevro Corp.

D. Keith Grossman

D. Keith Grossman

Chairman, CEO & President
Michael Demane

Michael Demane

Lead Director
David Caraway

David Caraway

Chief Medical Officer
Kevin O'Boyle

Kevin O'Boyle

Director
Rod MacLeod

Rod MacLeod

Chief Financial Officer
Niamh Pellegrini

Niamh Pellegrini

Chief Commercial Officer
Show more

Nevro Corp. Office Locations

Nevro Corp. has offices in Redwood City, Melbourne, München, Kanton Reinach and in 1 other location
Redwood City, CA, US (HQ)
1800 Bridge Pkwy
Melbourne, AU
Level 14/440 Collins St
München, DE
Prielmayerstraße 3
Kanton Reinach, CH
Christoph Merian-Ring 11
Cheltenham, GB
Carrick House, Lypiatt Rd
Show all (5)

Nevro Corp. Financials and Metrics

Nevro Corp. Revenue

Embed Graph
View revenue for all periods
Nevro Corp.'s revenue was reported to be $362.05 m in FY, 2020
USD

Revenue (Q1, 2021)

88.6m

Gross profit (Q1, 2021)

62.3m

Gross profit margin (Q1, 2021), %

70.3%

Net income (Q1, 2021)

(29.6m)

EBIT (Q1, 2021)

(22.5m)

Market capitalization (11-Jun-2021)

5.5b

Closing stock price (11-Jun-2021)

158.2

Cash (31-Mar-2021)

86.5m

EV

5.7b
Nevro Corp.'s current market capitalization is $5.5 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

32.6m69.6m228.5m326.7m387.3m390.3m362.0m

Revenue growth, %

114%228%

Cost of goods sold

11.3m28.1m75.4m99.0m114.0m121.9m112.1m

Gross profit

21.3m41.5m153.1m227.7m273.3m268.4m249.9m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

25.3m87.0m41.4m42.8m51.3m65.4m44.6m

Accounts Receivable

22.5m52.8m67.3m80.7m82.8m77.7m

Prepaid Expenses

6.5m6.6m9.8m4.2m

Inventories

62.4m85.2m98.1m92.0m91.6m83.3m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(30.7m)(67.4m)(31.8m)(36.7m)(49.2m)(103.7m)(83.1m)

Depreciation and Amortization

96.0k614.0k1.7m2.5m3.9m4.8m

Inventories

(5.5m)(49.4m)(27.0m)(16.3m)3.8m(938.0k)2.5m

Accounts Payable

1.3m17.1m(5.6m)2.2m5.2m(7.5m)7.7m
USDQ3, 2014

Financial Leverage

-0.5 x
Show all financial metrics

Nevro Corp. Operating Metrics

FY, 2016

Patents Issued

132

Patents Pending

101

Trademarks

16
Show all operating metrics

Nevro Corp. Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Nevro Corp. Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Nevro Corp. Online and Social Media Presence

Embed Graph

Nevro Corp. Company Culture

  • Overall Culture

    A+

    85/100

  • CEO Rating

    B+

    73/100

  • Compensation

    A+

    91/100

  • Diversity

    A

    84/100

Learn more on Comparably

Nevro Corp. News and Updates

Lifshitz & Miller LLP Announces Investigation of Corium International, Inc., Dragon Victory International Limited, Honeywell International Inc., Hortonworks, Inc., Idaho Independent Bank, L3 Technologies, Inc., MBT Financial Corp., Nevro Corp., and Ormat Technologies, Inc.

NEW YORK, Nov. 1, 2018 /PRNewswire/ -- Corium International, Inc. (CORI) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the sale of CORI to Gurnet Point Capital for $12.50 per share. If you are a Corium investor, and would like...

NEVRO HOLDINGS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nevro Corp. - NVRO

NEW ORLEANS, Sept. 21, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against Nevro Corp. (NYSE: NVRO), if they purchased the...

NEVRO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Nevro Corp. - NVRO

NEW ORLEANS, Aug. 31, 2018 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 22, 2018 to file lead plaintiff applications in a securities class action lawsuit against...

Nevro Corp. Frequently Asked Questions

  • When was Nevro Corp. founded?

    Nevro Corp. was founded in 2006.

  • Who are Nevro Corp. key executives?

    Nevro Corp.'s key executives are D. Keith Grossman, Michael Demane and David Caraway.

  • How many employees does Nevro Corp. have?

    Nevro Corp. has 853 employees.

  • What is Nevro Corp. revenue?

    Latest Nevro Corp. annual revenue is $362 m.

  • What is Nevro Corp. revenue per employee?

    Latest Nevro Corp. revenue per employee is $424.4 k.

  • Who are Nevro Corp. competitors?

    Competitors of Nevro Corp. include Saluda Medical, EBR Systems and Lungpacer Medical.

  • Where is Nevro Corp. headquarters?

    Nevro Corp. headquarters is located at 1800 Bridge Pkwy, Redwood City.

  • Where are Nevro Corp. offices?

    Nevro Corp. has offices in Redwood City, Melbourne, München, Kanton Reinach and in 1 other location.

  • How many offices does Nevro Corp. have?

    Nevro Corp. has 5 offices.